Replimune Group Inc share price today

(REPL)

Replimune Group Inc share price is $13.08 & ₹1,107.75 as on 7 Dec 2024, 2.30 'hrs' IST

$13.08

▲

0.03

(0.23%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Replimune Group Inc share price in Dollar and Rupees. Guide to invest in Replimune Group Inc from India. Also see the sentimental analysis on Indian investors investing in Replimune Group Inc. Get details on the Indian mutual funds that are investing in Replimune Group Inc. Get Analyst recommendations and forecasts along with all the Replimune Group Inc's financials.

Replimune Group Inc share price movements

$12.93
$13.17
$13.08
1.15%
Downside
Day's Volatility :1.82%
Upside
0.68%
$4.92
$17.00
$13.08
62.39%
Downside
52 Weeks Volatility :71.06%
Upside
23.06%

Replimune Group Inc Returns

Period	Replimune Group Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	23.93%	-5.7%	0.0%
6 Months	45.0%	-0.9%	0.0%
1 Year	79.01%	10.0%	0.0%
3 Years	-55.34%	9.3%	-21.5%

Replimune Group Inc Key Statistics

in dollars & INR

Previous Close	$13.05
Open	$13.11
Today's High	$13.17
Today's Low	$12.93
Market Capitalization	$1.0B
Today's Volume	$636.6K
52 Week High	$17.0
52 Week Low	$4.92
Revenue TTM	$0.0
EBITDA	$-226.7M
Earnings Per Share (EPS)	$-3.04
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-50.32%

How to invest in Replimune Group Inc from India?

It is very easy for Indian residents to invest directly in Replimune Group Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Replimune Group Inc stock in both rupees (INR) and dollars (USD). Search for Replimune Group Inc or REPL on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Replimune Group Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Replimune Group Inc shares which would translate to 0.065 fractional shares of Replimune Group Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Replimune Group Inc

567%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Replimune Group Inc on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 567% more investors are searching Replimune Group Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Replimune Group Inc

Baker Bros Advisors LP
14.35%
T. Rowe Price Associates, Inc.
12.84%
FCPM III SERVICES BV
6.32%
Redmile Group, LLC
6.21%
BlackRock Inc
6.13%
Vanguard Group Inc
4.50%

Analyst Recommendation on Replimune Group Inc

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Replimune Group Inc(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Replimune Group Inc

What analysts predicted

Upside of 29.01%

Current:

$13.08

Target:

$16.88

Insights on Replimune Group Inc

Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.7% return, outperforming this stock by 94.9%

Replimune Group Inc Technicals Summary

Sell

Neutral

Buy

Replimune Group Inc is currently in a neutral trading position according to technical analysis indicators.

Replimune Group Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Replimune Group Inc	6.88%	45.0%	79.01%	-55.34%	-7.32%
Regeneron Pharmaceuticals, Inc.	-6.86%	-23.34%	-8.6%	17.41%	110.02%
Biontech Se	10.16%	21.29%	14.9%	-59.29%	309.79%
Alnylam Pharmaceuticals, Inc.	-7.5%	64.08%	48.09%	42.33%	108.61%
Vertex Pharmaceuticals Incorporated	-8.46%	-4.83%	31.35%	122.6%	109.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Replimune Group Inc	NA	NA	NA	-3.27	-0.5	-0.27	NA	5.58
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Replimune Group Inc	Buy	$1.0B	-7.32%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	110.02%	18.56	33.61%
Biontech Se	Buy	$28.5B	309.79%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.61%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	109.65%	32.84	-4.51%

About Replimune Group Inc

replimune group, inc., a biotechnology company, develops oncolytic immune-gene therapies to treat cancer. it uses its proprietary immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. the company's lead product candidate is rp1, a selectively replicating version of herpes simplex virus 1, which is in phase i/ii clinical trials for a range of solid tumors; and that is in phase ii clinical trials for patients with cutaneous squamous cell carcinoma. it is also developing rp2, which is in phase i clinical trials for an anti-ctla-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by ctla-4; and rp3 to express immune-activating proteins that stimulate t cells. replimune group, inc. was founded in 2015 and is headquartered in woburn, massachusetts.

Organization	Replimune Group Inc
Employees	331
CEO	Mr. Philip Astley-Sparke F.S.A.
Industry	Health Technology

Management People of Replimune Group Inc

Name	Title
Mr. Philip Astley-Sparke F.S.A.	Executive Chairman
Ms. Emily Luisa Hill	Chief Financial Officer
Dr. Konstantinos Xynos M.B.A., M.D., Ph.D.	Chief Medical Officer
Dr. Sushil Patel Ph.D.	CEO & Director
Dr. Robert Coffin Ph.D.	Founder, Chief Scientist & Director
Mr. Andrew Schwendenman	Chief Accounting Officer & Treasurer
Mr. Christopher Sarchi	Chief Commercial Officer
Mr. Paul Bullock	Chief Manufacturing Officer & Framingham Site Head

Important FAQs about investing in Replimune Group Inc from India :

What is Replimune Group Inc share price today?

Replimune Group Inc (REPL) share price today is $13.08.

Can Indians buy Replimune Group Inc shares?

Yes, Indians can invest in the Replimune Group Inc (REPL) from India.

With INDmoney, you can buy Replimune Group Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Replimune Group Inc at zero transaction cost.

How can I buy Replimune Group Inc shares from India?

It is very easy to buy Replimune Group Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Replimune Group Inc be purchased?

Yes, you can buy fractional shares of Replimune Group Inc with INDmoney app.

What are the documents required to start investing in Replimune Group Inc stocks?

To start investing in Replimune Group Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.